Afrouz Nayernama

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Afrouz Nayernama is an author at Center for Drug Evaluation and Research specializing in pharmacology, adverse event reporting forms, and ventricular arrhythmia mechanisms.

ORCID

Publications per year

2017–2018

Publications

Ibrutinib‐associated <i>Pneumocystis jirovecii</i> pneumonia

Regina Lee, Afrouz Nayernama, S. Christopher Jones et al. · American Journal of Hematology · 2017 · 25 citations

Pharmacy, Infectious Diseases, Pharmacology +12

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Connie Cheng, Daniel Woronow, Afrouz Nayernama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

Medicine, Cardiology, Pharmacology +16

Wound healing complications with lenvatinib identified in a pharmacovigilance database

Connie Cheng, Afrouz Nayernama, S. Christopher Jones et al. · Journal of Oncology Pharmacy Practice · 2018 · 19 citations

Veterinary Medicine, Pharmacology, Surgery +13

1–3 of 3